NT_1170x120_1-11-18

tadalafil tablets

Aurobindo receives FDA approval for tadalafil tablets

Aurobindo receives FDA approval for tadalafil tablets

EAST WINDSOR, N.J. — Aurobindo has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for tadalafil tablets USP, 20 mg. Aurobindo’s tadalafil tablets is an AB-rated generic equivalent to the reference listed drug, Eli Lilly’s Adcirca. Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary

Camber Pharmaceuticals launches generic Adcirca

Camber Pharmaceuticals launches generic Adcirca

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of tadalafil tablets to our growing portfolio of products. Tadalafil tablets are the generic version of Adcirca from Eli Lilly Co. and is used to treat pulmonary arterial hypertension. Tadalafil tablets are available in a 20mg – 30 count bottle. Camber’ said its commitment to

Mylan launches first generic for Adcirca tablets

Mylan launches first generic for Adcirca tablets

HERTFORDSHIRE, England and PITTSBURGH — Mylan N.V. announced the U.S. launch of tadalafil tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and company’s Adcirca.  Mylan Pharmaceuticals received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) and was awarded 180 days of